Transgenic models of LGMD1A: expression of altered human myotilin results in a dominant-negative phenotype.

被引：0
|
作者：
Garvey, SM
Christine, KS
Wetsel, WC
Rodriguiz, RM
Conde, CB
Kowaljow, V
Stajich, JM
Gaskell, PC
Vance, JM
Pericak-Vance, MA
Rosa, AL
Hauser, MA
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Consejo Nacl Invest Cient & Tecn, INIMEC, Inst Invest Med Merceds & Martin Ferreyra, Cordoba, Argentina
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2002年 / 71卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
159
引用
收藏
页码：195 / 195
页数：1
相关论文
共 25 条
  • [1] EXPRESSION OF DOMINANT-NEGATIVE HUMAN INSULIN-RECEPTORS IN TRANSGENIC MICE
    CHANG, PY
    BENECKE, H
    MOLLER, DE
    DIABETES, 1994, 43 : A144 - A144
  • [2] EXPRESSION OF A DOMINANT-NEGATIVE MUTANT HUMAN INSULIN-RECEPTOR IN THE MUSCLE OF TRANSGENIC MICE
    CHANG, PY
    BENECKE, H
    LEMARCHANDBRUSTEL, Y
    LAWITTS, J
    MOLLER, DE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (23) : 16034 - 16040
  • [3] Diabetic phenotype of transgenic pigs introduced by dominant-negative mutant hepatocyte nuclear factor 1α
    Umeyama, Katihiro
    Nakajima, Masami
    Yokoo, Takashi
    Nagaya, Masaki
    Nagashima, Hfroshi
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (05) : 796 - 803
  • [4] Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation
    Saunier, E
    Dif, F
    Kelly, PA
    Edery, M
    ENDOCRINOLOGY, 2003, 144 (06) : 2669 - 2675
  • [5] TARGETING EXPRESSION OF A DOMINANT-NEGATIVE RETINOIC ACID RECEPTOR MUTANT IN THE EPIDERMIS OF TRANSGENIC MICE RESULTS IN LOSS OF BARRIER FUNCTION
    IMAKADO, S
    BICKENBACH, JR
    BUNDMAN, DS
    ROTHNAGEL, JA
    ATTAR, PS
    WANG, XJ
    WALCZAK, VR
    WISNIEWSKI, S
    POTE, J
    GORDON, JS
    HEYMAN, RA
    EVANS, RM
    ROOP, DR
    GENES & DEVELOPMENT, 1995, 9 (03) : 317 - 329
  • [6] Transgenic mice overexpressing human KvLQT1 dominant-negative isoform Part II: Pharmacological profile
    Lande, G
    Demolombe, S
    Bammert, A
    Moorman, A
    Charpentier, F
    Escande, D
    CARDIOVASCULAR RESEARCH, 2001, 50 (02) : 328 - 334
  • [7] Transgenic mice overexpressing human KvLQT1 dominant-negative isoform Part I: Phenotypic characterisation
    Demolombe, S
    Lande, G
    Charpentier, F
    van Roon, MA
    van den Hoff, MJB
    Toumaniantz, G
    Baro, I
    Guihard, G
    Le Berre, N
    Corbier, A
    de Bakker, J
    Opthof, T
    Wilde, A
    Moorman, AFM
    Escande, D
    CARDIOVASCULAR RESEARCH, 2001, 50 (02) : 314 - 327
  • [8] TARGETED EXPRESSION OF A DOMINANT-NEGATIVE RETINOIC ACID RECEPTOR MUTANT IN THE EPIDERMIS OF TRANSGENIC MICE RESULTS IN LOSS OF BARRIER FUNCTION AND NEONATAL LETHALITY
    IMAKADO, S
    BICKENBACH, J
    ROTHNAGEL, JA
    BUNDMAN, D
    WALCZAK, VR
    WISNIEWSKI, S
    GORDON, JS
    HEYMAN, R
    ROOP, DR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) : 547 - 547
  • [9] EXCHANGE OF FUNCTIONAL DOMAINS BETWEEN REV PROTEINS OF HIV-1 AND SIVMAC239 RESULTS IN A DOMINANT-NEGATIVE PHENOTYPE
    BERCHTOLD, S
    RIES, J
    HORNUNG, U
    AEPINUS, C
    VIROLOGY, 1994, 204 (01) : 436 - 441
  • [10] Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment
    Nagai, Taku
    Kitahara, Yuko
    Ibi, Daisuke
    Nabeshima, Toshitaka
    Sawa, Akira
    Yamada, Kiyofumi
    BEHAVIOURAL BRAIN RESEARCH, 2011, 225 (01) : 305 - 310
123